Zobrazeno 1 - 10
of 87
pro vyhledávání: '"B. von Graffenried"'
Autor:
Eberhard Standl, Jørn Nerup, Calvin R. Stiller, M. H. Tan, R. McArthur, K. Dawson, John Dupre, B. von Graffenried, Veikko A. Koivisto, F. A. Gries, Hubert Kolb, P. Hamet, Guntram Schernthaner, S. Martin, A. E. Mehta, S. Van Vliet
Publikováno v:
Diabetologia. 34(6)
In the Canadian/European randomized controlled study on cyclosporin A (CsA) in recent onset Type 1 (insulin-dependent) diabetes, treatment with the immunosuppressive drug had increased and maintained Beta-cell function and clinical remission during t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f3e96ecb5a696dfe450aeb966d6a65af
https://pubmed.ncbi.nlm.nih.gov/1884902
https://pubmed.ncbi.nlm.nih.gov/1884902
Autor:
G, Feutren, B, von Graffenried
Publikováno v:
Schweizerische medizinische Wochenschrift. 121(20)
Pilot studies with cyclosporin A (CsA, Sandimmun) in more than 100 patients with Crohn's disease have shown that CsA was more efficient in chronic active disease than in acute attacks. The onset of effect was rapid, usually within the first month, bu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::e082623a335bc78bf521c48f9a2e0009
https://pubmed.ncbi.nlm.nih.gov/2057741
https://pubmed.ncbi.nlm.nih.gov/2057741
Publikováno v:
The British journal of dermatology. 122
The efficacy of cyclosporin A (CyA) in severe psoriasis was analysed in 457 adult patients included in five European multicentre dose-finding studies. Initial CyA doses were 1.25 mg/kg/day in 33 patients, 2.5-3 mg/kg/day in 285 and 5 mg/kg/day in 139
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d82c812c3ecaf8fc0c9f888e101c7e4a
https://pubmed.ncbi.nlm.nih.gov/2196082
https://pubmed.ncbi.nlm.nih.gov/2196082
Publikováno v:
The British journal of dermatology. 122
Serum creatinine and blood pressure were measured in patients who had severe psoriasis and who were treated with cyclosporin A (CyA) in initial doses of 1.25 mg (n = 34), 2.5 or 3 mg (n = 314), or 5 (n = 215) mg/kg/day. Of the 563 patients involved,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::82febd48f830015e9f385c8cf1eac3f8
https://pubmed.ncbi.nlm.nih.gov/2196085
https://pubmed.ncbi.nlm.nih.gov/2196085
Publikováno v:
The Lancet. 335:1352
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::55a3f0d000868989dc9826cf47ca6466
https://doi.org/10.1016/0140-6736(90)91238-6
https://doi.org/10.1016/0140-6736(90)91238-6
Autor:
Erich Nüesch, B von Graffenried
Publikováno v:
British Journal of Clinical Pharmacology. 10:225S-231S
1 Eight double-blind, randomized, placebo-controlled, single-dose, cross-over studies were carried out to evaluate the usefulness of testing the acute analgesic effect of drugs in out-patients with non-migrainous headache. 2 The reference compounds w
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::adec39db04cb08dc60944dfaa29c13e8
https://doi.org/10.1111/j.1365-2125.1980.tb01804.x
https://doi.org/10.1111/j.1365-2125.1980.tb01804.x
Publikováno v:
Hormone Research. 13:90-97
The endocrine profile of FK 33-824, 0.5 mg i.m., was determined in comparison with placebo or pretreatment with naloxone, 4 mg i.v., in 14 healthy men. Prolactin (PRL), growth hormone (GH), ACTH, cortisol, gonadotropins (LH, FSH), thyrotropin (TSH),
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6d15425f2ecd2e5950203451e0a021db
https://doi.org/10.1159/000179275
https://doi.org/10.1159/000179275
Publikováno v:
European Journal of Clinical Pharmacology. 18:479-482
The usefulness of the dental outpatient model for evaluating the efficacy of mild analgesics, first described by Cooper and Beaver, is demonstrated in five separate, double-blind, randomised, single-dose, parallel-group studies. Pain intensity and pa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::828099b253fc2507dffa31b553dcade8
https://doi.org/10.1007/bf00874659
https://doi.org/10.1007/bf00874659
Autor:
B. von Graffenried
Publikováno v:
American Journal of Nephrology. 9:51-56
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::fb8abe1fe414f17e9b4f7b923adec2c2
https://doi.org/10.1159/000168039
https://doi.org/10.1159/000168039
Autor:
P. A. Keown, R. Martell, B. M. J. Wolfe, M. Gent, John Dupre, N. W. Rodger, M. R. Jenner, Calvin R. Stiller, B. von Graffenried, Andreas Laupacis
Publikováno v:
Science (New York, N.Y.). 223(4643)
Type I diabetes may be an autoimmune disorder, although the evidence is largely circumstantial. The natural history of the disease after diagnosis includes partial remission in most patients, but only about 3 percent achieve transient insulin indepen
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::07d635dc14f2a131c7e1fa201c6c53fe
https://pubmed.ncbi.nlm.nih.gov/6367043
https://pubmed.ncbi.nlm.nih.gov/6367043